APA (7th ed.) Citation

BR, T., LM, P., CL, N., J, G., AB, M., RO, J., . . . J, S. (2022). MicroRNA and metabolomics signatures for adrenomyeloneuropathy disease severity. JIMD reports, 63(6), 593. https://doi.org/10.1002/jmd2.12323

Chicago Style (17th ed.) Citation

BR, Turk, Poisson LM, Nemeth CL, Goodman J, Moser AB, Jones RO, Fatemi A, and Singh J. "MicroRNA and Metabolomics Signatures for Adrenomyeloneuropathy Disease Severity." JIMD Reports 63, no. 6 (2022): 593. https://doi.org/10.1002/jmd2.12323.

MLA (9th ed.) Citation

BR, Turk, et al. "MicroRNA and Metabolomics Signatures for Adrenomyeloneuropathy Disease Severity." JIMD Reports, vol. 63, no. 6, 2022, p. 593, https://doi.org/10.1002/jmd2.12323.